- Acumen Powered by Robins Kaplan LLP®
- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Entertainment and Media Litigation
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Fiduciary Disputes
Acumen Powered by Robins Kaplan LLP®
Ediscovery, Applied Science and Economics, and Litigation Support Solutions
-
November 20, 2024Eighth Circuit Affirms U.S. Merchants Victory in Trade Dress Infringement Case
-
November 15, 2024Lauren Coppola Named an Emerging Leader by Profiles in Diversity Journal
-
November 11, 2024Tommy Du Honored With 2024 Sheila Sonenshine Associate Pro Bono Award
-
December 3, 2024Can You Keep a Secret? Privacy Laws and Civil Litigation
-
December 11, 20242024 Year in Review: eDiscovery and Artificial Intelligence
-
December 12, 2024Strategies for Licensing AI: A Litigation Perspective
-
November 8, 2024Trademark tensions on the track: Court upholds First Amendment protections in Haas v. Steiner
-
November 8, 2024Destination Skiing And The DOJ's Mountain Merger Challenge
-
November 6, 2024How Recent Patent Damages Precedent May Increase Reasonable Royalty Awards
-
September 16, 2022Uber Company Systems Compromised by Widespread Cyber Hack
-
September 15, 2022US Averts Rail Workers Strike With Last-Minute Tentative Deal
-
September 14, 2022Hotter-Than-Expected August Inflation Prompts Massive Wall Street Selloff
Find additional firm contact information for press inquiries.
Find resources to help navigate legal and business complexities.
Read our attorneys' take on the latest news and trends in the legal and business industries.
Generic Launches
Winter 2020
Reference Listed Drug | NDA Holder | Generic Drug Name | ANDA Applicant(s) |
Indication | Launch Date |
---|---|---|---|---|---|
Remodulin | United Therapeutics | treprostinil | Teva | Used to treat Pulmonary Arterial Hypertension (PAH). | 10/1/2019 |
Xyzal | UCB | levocetirizine | Camber (Hetero) | Used to treat symptoms associated with perennial allergic rhinitis in children 6 months to 2 years of age; for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 6 months of age and older. | 10/1/2019 |
Invega | Johnson and Johnson | paliperidone | Amneal | Used to treat the symptoms of schizophrenia. | 10/10/2019 |
OsmoPrep | Salix | sodium phosphate monobasic monohydrate / sodium phosphate dibasic anhydrous | Novel/Teva | Used for cleansing of the colon as a preparation for colonoscopy in adults. | 10/16/2019 |
Bentyl | Allergan | dicyclomine | Camber (Hetero) | Used to treat the symptoms of irritable bowel syndrome. | 11/4/2019 |
Tarceva | Genentech | erlotinib | Breckenridge | Used to treat patients with metastatic non-small cell lung cancer whose tumors have epidermal growth factor receptor exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test receiving first-line, maintenance, or second or greater line treatment after progression following at least one prior chemotherapy regimen and also for the first-line treatment of patients with locally advanced, unresectable or metastatic pancreatic cancer in combination with gemcitabine. | 11/12/2019 |
Emend | Merck | fosaprepitant | Fresenius Kabi | Used along with other medications to prevent nausea and vomiting in adults that may occur within 24 hours or several days after receiving certain cancer chemotherapy treatments. | 11/13/2019 |
Tarceva | Genentech | erlotinib | Armas | Used to treat patients with metastatic non-small cell lung cancer whose tumors have epidermal growth factor receptor exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test receiving first-line, maintenance, or second or greater line treatment after progression following at least one prior chemotherapy regimen and also for the first-line treatment of patients with locally advanced, unresectable or metastatic pancreatic cancer in combination with gemcitabine. | 11/13/2019 |
Potassium Chloride | Pharma Research Software Solution | potassium chloride | Lupin | Used to treat or prevent low amounts of potassium in the blood. | 11/19/2019 |
BiCNU | Avet Pharma (Emcure) | carmustine | STI Pharma | Used to treat brain tumors, multiple myeloma, Hodgkin's disease and Non-Hodgkin's lymphomas. | 11/21/2019 |
Hectorol | Sanofi | doxercalciferol | Dr. Reddy's | Used to treat secondary hyperparathyroidism in certain people with chronic kidney disease and in those treated with dialysis. | 11/22/2019 |
Westcort | Sun | hydrocortisone valerate cream 0.2% | Lupin | Used for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses in adult patients. | 11/22/2019 |
Jadenu | Novartis | deferasirox | Teva | Used to treat chronically elevated levels of iron in the blood caused by repeated blood transfusions (transfusional hemosiderosis) in patients 2 years of age and older. | 11/26/2019 |
Revatio | Pfizer | sildenafil | Amneal | Used to treat erectile dysfunction in men. | 12/2/2019 |
Exelon Patch | Novartis | rivastigmine | Breckenridge | Used to treat dementia associated with mild, moderate and severe Alzheimer's Disease and the treatment of mild to moderate dementia associated with Parkinson's Disease. | 12/3/2019 |
Velcade | Millenium | bortezomib | Dr. Reddy's | Used to treat adults with multiple myeloma and the treatment of adults with mantle cell lymphoma. | 12/4/2019 |
Exjade | Novartis | deferasirox | Dr. Reddy's | Used for the treatment of chronic iron overload due to blood transfusions inpatients two years of age and older. | 12/6/2019 |
Jadenu | Novartis | deferasirox | Dr. Reddy's | Used to treat chronically elevated levels of iron in the blood caused by repeated blood transfusions (transfusional hemosiderosis) in patients 2 years of age and older. | 12/6/2019 |
Afinitor | Novartis | everolimus | Par | Used to treat advanced renal cell carcinoma that has already been treated unsuccessfully with other medications; to treat a certain type of advanced breast cancer that has already been treated with at least one other medication; to treat a certain type of cancer of the pancreas, stomach, intestines, or lungs that has spread or progressed and that cannot be treated with surgery; to treat kidney tumors in people with tuberous sclerosis complex; to treat subependymal giant cell astrocytoma in adults and children 1 year of age and older who have TSC. | 12/10/2019 |
NuvaRing | Merck | etonogestrel / ethinyl estradiol | Amneal | Used to prevent pregnancy. | 12/12/2019 |
Invanz | Merck | ertapenem | Fresenius Kabi | Used to treat adult patients and pediatric patients (3 months of age and older) with the moderate to severe infections caused by susceptible isolates of the designated microorganisms in complicated intra-abdominal infections, complicated skin and skin structure infections, including diabetic foot infections without osteomyelitis, community acquired pneumonia, compicated urinary tract infections including pyelonephritis and acute pelvic infections including postpartum endomyometritis, septic abortion and post surgical gynecologic infections. | 12/12/2019 |
NuvaRing | Merck | etonogestrel / ethinyl estradiol | Prasco | Used to prevent pregnancy. | 12/16/2019 |
Hectorol | Genzyme | doxercalciferol | Lupin | Used to treat secondary hyperparathyroidism in certain people with chronic kidney disease and in those treated with dialysis. | 12/19/2019 |
Travatan Z | Alcon (Novartis) | travoprost | Apotex | Used for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. | 12/19/2019 |
Nitopress | Hospira | sodium nitroprusside | Dr. Reddy's | Used for the immediate reduction of blood pressure of adult and pediatric patients in hypertensive crises. Concomitant longer-acting antihypertensive medication should be administered so that the duration of treatment with sodium nitroprusside can be minimized; for producing controlled hypotension in order to reduce bleeding during surgery; for the treatment of acute congestive heart failure. | 12/30/2019 |
GENERICally Speaking Winter 2020
Related Professionals
Christopher A. Pinahs
Partner
Haroon N. Mian
Associate
GENERICally Speaking Winter 2020
VOL. 9, NO. 4 Related Publications
September 18, 2024
Astellas Pharma, Inc. v. Sandoz Inc.
GENERICally Speaking Hatch Waxman Bulletin
September 9, 2024
Purdue Pharma L.P v. Accord Healthcare Inc.
GENERICally Speaking Hatch Waxman Bulletin
September 4, 2024
Exeltis USA, Inc. v. Lupin Ltd.
GENERICally Speaking Hatch Waxman Bulletin
August 28, 2024
Teva Branded Pharm. Products R&D, Inc. v. Deva Holding A.S.
GENERICally Speaking Hatch Waxman Bulletin
August 13, 2024
Allergan USA, Inc. v. MSN Labs. Private Ltd.
GENERICally Speaking Hatch Waxman Bulletin
Related News
October 14, 2022
September 9, 2022
Back to Top
Any information that you send us in an e-mail message should not be confidential or otherwise privileged information. Sending us an e-mail message will not make you a client of Robins Kaplan LLP. We do not accept representation until we have had an opportunity to evaluate your matter, including but not limited to an ethical evaluation of whether we are in a conflict position to represent you. Accordingly, the information you provide to us in an e-mail should not be information for which you would have an expectation of confidentiality.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.